JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaji, H.
Right arrow Articles by Chihara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaji, H.
Right arrow Articles by Chihara, K.

J Biol Chem, Vol. 273, Issue 51, 33885-33888, December 18, 1998

COMMUNICATION
Cloning and Characterization of the 5'-Flanking Region of the Human Growth Hormone Secretagogue Receptor Gene

Hidesuke Kaji, Shigeru Tai, Yasuhiko Okimura, Genzo Iguchi, Yutaka Takahashi, Hiromi Abe, and Kazuo Chihara

From the Third Division, Department of Medicine, Kobe University School of Medicine, Kobe 650-0017, Japan

Recently, the growth hormone secretagogue receptor (GHS-R) cDNA has been isolated from the pituitary and hypothalamus. To evaluate the regulation of human (h) GHS-R gene expression, we cloned the hGHS-R gene containing the 5'-flanking region of 0.6-2.9 kilobase pairs. Analysis of the hGHS-R transcripts with 5'-rapid amplification of cDNA ends suggested that the putative transcription initiation site was approximately -453 base pairs upstream of the translation initiation site (+1). There is no typical TATA, CAAT, or GC box but an initiator-like sequence and putative binding sites for several transcription factors around the putative transcription start site. The 5'-flanking region inserted into a luciferase reporter vector had promoter activity in GH3 cells but had activity indistinguishable from background in HeLa or EP1 cells. The hGHS-R promoter activity in GH3 cells increased by deletion of nucleotides from -1224 to -734, whereas it was decreased by further deletion from -734 to -608. Knowledge of the promoter region of the hGHS-R gene will facilitate elucidation of its transcriptional control.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J EndocrinolHome page
C.-M. Yeung, C.-B. Chan, N. Y S Woo, and C. H K Cheng
Seabream ghrelin: cDNA cloning, genomic organization and promoter studies.
J. Endocrinol., May 1, 2006; 189(2): 365 - 379.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. Lynch, D. G. Scofield, and X. Hong
The Evolution of Transcription-Initiation Sites
Mol. Biol. Evol., April 1, 2005; 22(4): 1137 - 1146.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. M. Luque, R. D. Kineman, S. Park, X.-D. Peng, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon
Homologous and Heterologous Regulation of Pituitary Receptors for Ghrelin and Growth Hormone-Releasing Hormone
Endocrinology, July 1, 2004; 145(7): 3182 - 3189.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Richmond, A. D. Rogol, D. Basdemir, O. L. Veldhuis, W. Clarke, C. Y. Bowers, and J. D. Veldhuis
Accelerated Escape from GH Autonegative Feedback in Midpuberty in Males: Evidence for Time-Delimited GH-Induced Somatostatinergic Outflow in Adolescent Boys
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3837 - 3844.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Anderson, L. Wideman, J. T. Patrie, A. Weltman, C. Y. Bowers, and J. D. Veldhuis
E2 Supplementation Selectively Relieves GH's Autonegative Feedback on GH-Releasing Peptide-2-Stimulated GH Secretion
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5904 - 5911.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Petersenn, A. C. Rasch, M. Penshorn, F. U. Beil, and H. M. Schulte
Genomic Structure and Transcriptional Regulation of the Human Growth Hormone Secretagogue Receptor
Endocrinology, June 1, 2001; 142(6): 2649 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Anderson, N. Shah, W. S. Evans, J. T. Patrie, C. Y. Bowers, and J. D. Veldhuis
Short-Term Estradiol Supplementation Augments Growth Hormone (GH) Secretory Responsiveness to Dose-Varying GH-Releasing Peptide Infusions in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 551 - 560.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis
Oral Estradiol Administration Modulates Continuous Intravenous Growth Hormone (GH)-Releasing Peptide-2-Driven GH Secretion in Postmenopausal Women
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2649 - 2659.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.